Indirect hyperbilirubinemia caused by cyclosporine.
Kimyai-Asadi
Arash
A
Ronald O. Perelman Department of Dermatology, The New York University School of Medicine, NY 10016, USA.
Jih
Ming H
MH
D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*
D003879:Dermatologic Agents; D016572:Cyclosporine